Pönisch, Wolfram <br/><br/>
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Mar 2013 
 - 499-508 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-012-1339-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bendamustine Hydrochloride<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Nitrogen Mustard Compounds--administration & dosage<br/>Prednisone--administration & dosage<br/>Pyrazines--administration & dosage<br/>Recurrence<br/>Retrospective Studies